• 咨询热线
    客服服务热线 13671568941/15317326293
  • 在线咨询
  • 微信客服
    微信客服
  • 公众号
    扫码关注公众号

ALK-IN-26

CAS No. 2447607-85-2

ALK-IN-26 ( —— )

产品货号. M37104 CAS No. 2447607-85-2

ALK-IN-26 (compound 4a) 是 ALK 抑制剂,对 ALK 酪氨酸激酶的 IC50 值为7.0 μM。ALK-IN-26 有良好的药代动力学特性和血脑屏障通透性。ALK-IN-26 能够引起细胞凋亡、自噬和坏死。ALK-IN-26 能够用于胶质母细胞瘤研究。

纯度: >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
规格 价格/人民币 库存 数量
2MG ¥452 有现货
5MG ¥638 有现货
10MG ¥993 有现货
25MG ¥1869 有现货
50MG ¥2956 有现货
100MG ¥4276 有现货
500MG ¥9104 有现货
1G 获取报价 有现货

生物学信息

  • 产品名称
    ALK-IN-26
  • 注意事项
    本公司产品仅用于科研实验,不得用于人体或动物的临床与诊断
  • 产品简述
    ALK-IN-26 (compound 4a) 是 ALK 抑制剂,对 ALK 酪氨酸激酶的 IC50 值为7.0 μM。ALK-IN-26 有良好的药代动力学特性和血脑屏障通透性。ALK-IN-26 能够引起细胞凋亡、自噬和坏死。ALK-IN-26 能够用于胶质母细胞瘤研究。
  • 产品描述
    ALK-IN-26 is an ALK inhibitor with IC50 value of 7.0 μM for ALK tyrosine kinase. ALK-IN-26 has good pharmacokinetic properties and blood-brain barrier (BBB) permeability. ALK-IN-26 can induce apoptosis, autophagy and necrosis. ALK-IN-26 can be used in glioblastoma studies.
  • 体外实验
    Apoptosis AnalysisCell Line:GL261 Concentration:0.5 μM, 1.0 μM, 2.0 μM Incubation Time:24 h, 48 h, 72 h Result:Induced apoptosis of glioblastoma in a concentration- and time-dependent manner, and caused the cells (24.5%) entered the S phase but barely proceeded to the G2/M phase when treated with 1 μM for 72 h.Cell Viability AssayCell Line:GL216, U87MG, HelaConcentration:0.5 μM, 1.0 μM, 2.0 μM, 5 μM, 10 μM for GL216 and U87MG cells 5 μM, 10 μM, 20 μM, 40 μM, 80 μM, 160 μM for Hela cells Incubation Time:24 h, 48h, 72h Result:Inhibited the activity of GL216 cells with the inhibition rate of cells at 80% when incubated with 2 μM for 72 h and inhibited U87MG cells viability with a dose- and time-dependent manner, while showed limited inhibition on Hela cells, even at 160 μM, the inhibition rate is less than 50%. Can inhibit the activity of ALK tyrosine kinase with a dose-dependent manner.Cell Autophagy Assay Cell Line:GL261 Concentration:0.5 μM, 1.0 μM, 2.0 μM Incubation Time:24 h Result: Induced autophagy death in glioblastoma cells.
  • 体内实验
    Animal Model:Male C57BL/6J miceDosage:5 mg/kgAdministration:Intravenous injection (i.v.), Single dose Result:Could be rapidly absorbed (Tmax = 0.58 h) with an acceptable half-life (T1/2 = 3.55 h) and bioavailability (F = 38.4%).Animal Model:Male C57BL/6J mice Dosage:20mg/kg Administration:Intraperitoneal injection (i.p.), Single doseResult:Could enter the body at concentrations up to 2.7μmol/kg (after 2 h administration at 20 mg/kg) andpenetrate the blood-brain barrier.
  • 同义词
    ——
  • 通路
    Angiogenesis
  • 靶点
    ALK
  • 受体
    ALK
  • 研究领域
    ——
  • 适应症
    ——

化学信息

  • CAS Number
    2447607-85-2
  • 分子量
    405.51
  • 分子式
    C24H23NO3S
  • 纯度
    >98% (HPLC)
  • 溶解度
    ——
  • SMILES
    O=S(=O)(C1=CC=C(C=C1)C)N2C=C(C=3C=CC=CC32)CC=4C=C(C(O)=C(C4)C)C
  • 化学全称
    ——

运输与储存

  • 储存条件
    (-20℃)
  • 运输条件
    With Ice Pack
  • 稳定性
    ≥ 2 years

参考文献

1. Feng L, et al. Synthesis and Bioevaluation of 3-(Arylmethylene) indole Derivatives: Discovery of a Novel ALK Modulator with Antiglioblastoma Activities[J]. Journal of Medicinal Chemistry, 2023.?
产品手册
关联产品
  • ALK-IN-27

    ALK-IN-27 (compound 1) 是一种有效的 ALK 抑制剂。ALK-IN-27 显示出抗肿瘤活性。对于 Ba/F3 CLIP1-LTK 细胞,ALK-IN-27 的 IC50 为 2.7 nM。

  • Lu AF21934

    Lu AF21934 是一种脑渗透性、选择性 mGlu4 受体正变构调节剂(IC50:500 nM,人)。

  • JH-VIII-157-02

    JH-VIII-157-02 是一种有效的、口服活性的、中枢神经系统可渗透的第二代 ALK G1202R 突变体抑制剂,IC50 为 2 nM。